National High-Tech Company
Tianjin Century Healthcare Biomedical Engineering Co., Ltd.

 Tianjin Shi Ji Kang Tai  Biomedical Engineering Co., Ltd. (hereinafter referred to as "Shi Ji Kang Tai ") is a Class-III high-end medical device manufacturing enterprise integrating research and development, production, and sales. Shi Ji Kang Tai  is located in the West District of Tianjin Development Zone with a GMP factory area of 20,000m². It established 10,000-level clean production workshop, and high-quality scientific research laboratory equipment with dual water production systems for purified and injection water, as well as an air purification system.

 Shi Ji Kang Tai takes " innovative ophthalmic materials and optical design " as its strategic scope, covering fields such as intraocular lenses, optometry, and biomaterial collagen.After more than a decade of development, Shi Ji Kang Tai  has been awarded a series of honorary titles including "National High-tech Enterprise", "National Key Little Giant Enterprise"Specializing in Sophisticated, Unique and Innovative Products, "Tianjin Gazelle Enterprise" and "Tianjin Leading Enterprise in Strategic Emerging Industries".In recent years, the company has been selected for the "2025 Rising Star of Innovative Medical Device Products" by the National Medical Device Innovation Center (NMED) and the "Top 100 List of China’s Medical Device R&D Comprehensive Strength 2025".It has been approved to establish a Sub-station of Postdoctoral Research Workstation, Tianjin Key Laboratory of Innovative Ophthalmic Optical Technology, and Graduate Workstation for Industry-Education Integration of Ophthalmology and Optometry. Meanwhile, our company has undertaken multiple major research projects, such as the Central Government-guided Local Science and Technology Development Fund Project of Tianjin and Major Special Science and Technology Projects for Public Health and Biomedicine of Tianjin.Shi Ji Kang Tai  is now included in the key cultivation list of enterprises to be listed in Binhai New Area, Tianjin.

National High-Tech Company
2008
Incorporation
20,000
Plan area
80
+
Number of patents
5
Wholly-owned subsidiaries
Products
Focusing on core medical technologies , upgrade solution continuously
Core advantages
Provide a full lifecycle ophthalmic diagnosis and treatment solution
The company has nearly 70 top global ophthalmic research and development talents, including 10 PhDs, 30 Masters, more than 30 senior professional titles, and more than 80 patents; The average industry experience of R&D personnel is nearly 10 years. The company has strong independent research and development capabilities and has established long-term strategic partnerships with multiple colleges and research institutes.
Our R&D team is able to quickly respond to market demand and has strong product technology transformation capabilities, enabling us to quickly achieve industrial production and promote it to the market. Our management team highly recognizes corporate culture.
The company has nearly 70 top global ophthalmic research and development talents, including 10 PhDs, 30 Masters, more than 30 senior professional titles, and more than 70 patents; The average industry experience of R&D personnel is nearly 10 years. The company has strong independent research and development capabilities and has established long-term strategic partnerships with multiple colleges and research institutes.
Our R&D team is able to quickly respond to market demand and has strong product technology transformation capabilities, enabling us to quickly achieve industrial production and promote it to the market. Our management team highly recognizes corporate culture.
News
We provide you with the latest news information and take you to learn more about our updates.